12.07.2015 Views

Бронхіальна астма - Міністерство охорони здоров'я України

Бронхіальна астма - Міністерство охорони здоров'я України

Бронхіальна астма - Міністерство охорони здоров'я України

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

373. Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM. Long-term safety and efficacyof a chlorofluorocarbon-free beclometasone dipropionate extrafine aerosol. Annals of Allergy, Asthma, &Immunology 2001;86(5):557-65.374. Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, et al. Growth,systemic safety, and efficacy during 1 year of asthma treatment with different beclometasone dipropionateformulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.Pediatrics. 2002;109(6):e92.375. Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, et al. Switchingfrom conventional to extrafine aerosol beclometasone dipropionate therapy in children: a 6-month,openlabel, randomized trial. Journal of Allergy & Clinical Immunology 2002;110(1):45-50.376. Ayres JG, Millar AB, Sykes AP. Clinical efficacy and safety of fluticasone propionate 1 mg twice dailyadministered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. RespiratoryMedicine 2000;94(Suppl B):S42-S50.377. Fowler SJ, Orr LC, Sims EJ, Wilson AM, Currie GP, McFarlane L, et al. Therapeutic ratio ofhydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate. Chest. 2002;122(2):618-23.378. Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A. Fluticasone propionate viathe Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airwayhyperresponsiveness. Chest. 2002;122(3):806-11.379. Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children. Canadian Respiratory Journal 2003;10(2):103-9.380. Perruchoud AP, Lundback B, Yigla M, Sykes AP. Clinical efficacy and safety of fluticasone propionate1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate tosevere asthma. Resp Med 2000;94(Suppl B):S35-S41.381. Accuracy of death certificates in bronchial asthma. Accuracy of certification procedures during theconfidential inquiry by the British Thoracic Association. A subcommittee of the BTA Research Committee.Thorax 1984;39(7):505-9.382. Bucknall CE, Slack R, Godley CC, Mackay TW, Wright SC. Scottish Confidential Inquiry into AsthmaDeaths (SCIAD), 1994-6. Thorax 1999;54(11):978-84.383. Burr ML, Davies BH, Hoare A, Jones A, Williamson IJ, Holgate SK, et al. A confidential inquiry intoasthma deaths in Wales. Thorax 1999;54(11):985-9.384. Mohan G, Harrison BD, Badminton RM, Mildenhall S, Wareham NJ. A confidential enquiry intodeaths caused by asthma in an English health region: implications for general practice. Br J Gen Pract1996;46(410):529-32.385. Wareham NJ, Harrison BD, Jenkins PF, Nicholls J, Stableforth DE. A district confidential enquiry intodeaths due to asthma. Thorax 1993;48(11):1117-20.386. Harrison BDW, Slack R, Berrill WT, Burr ML, Stableforth DE, Wright SC. Results of a nationalconfidential enquiry into asthma deaths. Asthma J 2000;5(4):180-6.387. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists andthe risk of death and near death from asthma. N Engl J Med 1992;326(8):501-6.388. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatalasthma. Eur Respir J 1994;7(9):1602-9.389. Jalaludin BB, Smith MA, Chey T, Orr NJ, Smith WT, Leeder SR. Risk factors for asthma deaths: Apopulation-based, case-control study. Aust NZ J Pub Health 1999;23(6):595-600.390. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deathsfrom asthma. Thorax 1986;41(11):833-9.391. Campbell MJ, Cogman GR, Holgate ST, Johnston SL. Age specific trends in asthma mortality inEngland and Wales, 1983-95: results of an observational study. BMJ 1997;314(7092):1439-41.392. Richards GN, Kolbe J, Fenwick J, Rea HH. Demographic characteristics of patients with severe lifethreatening asthma: comparison with asthma deaths. Thorax 1993;48(11):1105-9.393. Innes NJ, Reid A, Halstead J, Watkin SW, Harrison BD. Psychosocial risk factors in near-fatal asthmaand in asthma deaths. J R Coll Phys Lond 1998;32(5):430-4.394. Khot A, Evans N, Lenney W. Seasonal trends in childhood asthma in south east England. Br Med J(Clin Res Ed) 1983;287(6401):1257-8.245

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!